ARTERIAL HYPERTENSION IN PATIENTS WITH ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS
Keywords:
arterial hypertension, cardiovascular risk, ankylosing spondylitis, ankylosing spondylitis, psoriatic arthritisAbstract
The purpose of this work is to evaluate the occurrence of arterial hypertension (AH) and the frequency of new cases of its occurrence in patients with ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Materials and methods. The data from a single-stage survey of patients with AS (n = 159) and PsA (n = 85) were analyzed. Another part of the work was the analysis of data from a 10‑year prospective follow-up patients with AS (n = 278) and PsA (n = 109) were followed. The patient data were compared with the results of the examination of healthy individuals (n = 150). The comparison of individuals from three groups by cardiovascular risk factors was performed. Results. According to the simultaneous analysis, the incidence of hypertension in AS and PsA was 48.7% and 67.5%, respectively (p = 0.03). Relative risk (RR) of hypertension in patients AS compared with healthy individuals was 2.22 (95% CI 1.59–3.1), the odds ratio (OR) was 3.34 (95% CI 2.1–5.3). The risk of hypertension in patients with PsA compared with people without spondyloarthritis (RR) was 3.08 (95% CI 2.19–4.03). Conclusions. The risk of hypertension in patients with AS and PsA exceeds the risk of hypertension in healthy individuals. The incidence of hypertension and the frequency of new cases in PsA are higher than in AS. The number of new cases of hypertension increases over time in such a way that 10 years after diagnosis, every second patient has AS/PsA without cardiovascular diseases is at risk of hypertension.
References
1.Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). TIZIMLI QIZIL YUGURIK KASALLIGI. Научный Фокус, 2(19), 413-417.
2.Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). REVMATOID ARTRIT KASALLIGIDA METABOLIK REGULYASIYA. Научный Фокус, 2(19), 429-434.
3.Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). REVMATOID ARTRITDA STEROID DIABET OLDINI OLISH. Научный Фокус, 2(19), 425-428.
4.Sherbek o‘g‘li, U. R., & Ismailovich, N. A. (2024). REVMATOID ARTRIT KASALLIGIDA METORTRIT VA NOSTEROIDLARNI BIRGA QOLLASHDA TERAPEVTIK SAMARADORLIK. Научный Фокус, 2(19), 418-424.
5.Uralov, R. S., Omonov, S. A., & Zaripov, J. S. SOME INDICATORS OF THE HEMOSTASIS SYSTEM IN THROMBOCYTOPENIA OF DRUG AND NON-DRUG GENESIS IN THE CLINIC INTERNAL DISEASES. УЧЕНЫЙ XXI ВЕКА, 28(10), 79-88.
6.Ibragimov, K., Sultonov, I., & Ravshanova, M. (2024). The Effectiveness of the Combination Therapy with biologic DMARDS in Rheumatoid Arthritis. Frontiers of Global Science, 2(1), 17-24.
7.Ziyadullaev, S. K., Sultonov, I. I., Dushanova, G. A., & Akbarovna, K. S. (2021). The Effectiveness Of Pharmacotherapy For Dmards With Ra Depending On The C3435t Polymorphism Of The Mdr1 Gene. Int. J. of Aquatic Science, 12(3), 2908-2916.
8.Sobirov, A., & Sultonov, I. (2024). COMPREHENSIVE ANALYSIS OF CLINICAL NEUROPSYCHOLOGICAL AND NEUROIMAGING ASPECTS OF ALZHEIMER'S DISEASE. Frontiers of Global Science, 2(1), 25-29.
9.Islomovich, S. I. (2024). FEATURES OF THE COURSE OF PREGNANCY IN RHEUMATOID ARTHRITIS. International journal of medical sciences, 4(10), 77-84.
10.Islomovich, S. I. (2024). Gender characteristics of the current rheumatoid arthritis. International journal of medical sciences, 4(10), 3-8.
11.Kireev, V. V., Sultonov, I. I., Ziyadulaaev, S. K., Suyarov, A. A., Aripova, T. U., Usmanbekova, K. T., & Nasretdinova, M. T. (2021). Genetic Engineered Preparations-An Innovative Approach in the Treatment of Rheumatoid Arthritis. Annals of the Romanian Society for Cell Biology, 25(3), 4114-4119.
12.Hamraeva, N. A., Sultonov, I. I., & Hasanov, F. S. (2020). Systemic lupus erythematosus treatment strategy. Journal of Critical Reviews, 7(9), 269-270.
13.Иргашева, У. З., Султонов, И. И., & Тоиров, Д. Р. (2013). Признаки дебюта системной красной волчанки. Академический журнал Западной Сибири, 9(1), 15-15.
14.Xasanov, F. S., & Sultonov, I. I. (2023). RHEUMATOID ARTHRITIS TREATED WITH DMARDS AND CARDIOVASCULAR DISEASE RISK. Oriental Journal of Medicine and Pharmacology, 3(02), 45-52.
15.Sultonov, I. I., Xasanov, F. S., Eshmuratov, S., Uralov, R. S., Shukurova, D., & Ziyadullayev, S. X. Predictors of Systemic Lupus Erythematosus: A Case-control Study. International journal of health sciences, 6(S10), 175-182.
